Evaluating new monitoring technology for patients with pulmonary hypertension

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the safety and feasibility of using pulmonary artery pressure monitors and wearable activity monitors in patients diagnosed with pulmonary hypertension. The study will correlate data from these monitors to evaluate patient outcomes, including the frequency of medication changes, quality of life, and overall mortality. Eligible patients will undergo a thorough screening process, including medical history reviews and clinical examinations, to ensure they meet the inclusion criteria. The study will also involve baseline assessments such as a six-minute walk test and quality of life questionnaires.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of pulmonary hypertension (Group I,II,III and IV)
* Age 18 years
* Estimated glomerular filtration rate (eGFR) \> 25
* Body mass index (BMI) \< 35 (or equivalent)
* Pulmonary artery (PA) branch 7mm
* Negative pregnancy test (If female of childbearing age)
* Written, informed consent completed
* Willingness of the patient to comply

Exclusion Criteria:

* Group IV PH
* Active infection
* Pulmonary embolus (PE) or deep vein thrombosis (DVT)
* Major cardiovascular event within past 2 months
* Cardiac resynchronisation therapy (CRT) device within past 3 months
* Mechanical right heart valve
* Known coagulation disorder
* Known hypersensitivity to aspirin or clopidogrel.

Where it's running

• Sheffield Teaching Hospitals NHS Foundation Trust
  Sheffield, South Yorkshire, United Kingdom Recruiting

Study contacts

• Study coordinator: Alexander Rotherman
• Email: a.rothman@sheffield.ac.uk
• Phone: 0114 2509550

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

• Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

  This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Pulmonary Artery Denervation for Pulmonary Hypertension After M-TEER

  This study tests whether PADN can help people with pulmonary hypertension after M-TEER compared with standard medical therapy.

  Recruiting Early Phase 1 Xiamen Cardiovascular Hospital, Xiamen University · Xiamen, Fujian · NCT07662655

• Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

  This study tests how to identify people with pulmonary hypertension who are at risk of a sudden, life-threatening crisis.

  Recruiting at 4 sites Peking Union Medical College Hospital · Guangzhou, Guangdong and 3 other locations · NCT07653958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.